CERS
Medical Devices · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Cerus Corp publishes a filing, an earnings call transcript or a press release.
Get CERS alertsKevin Green is recorded as CFO at Cerus Corp (CERS). The newest filing on record that lists Kevin Green as CFO at Cerus Corp (CERS) is dated April 22, 2026. The proxy statement of Cerus Corp reports total compensation of $1,750,398 for Kevin Green in fiscal 2025, including a base salary of $507,440. Disclosed compensation is on record for 9 fiscal years. Kevin Green has spoken on 24 earnings calls across 1 company, most recently for Cerus Corp on July 30, 2026. Cerus Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Cerus Corp includes Vivek Jayaraman (CEO, COO and Board Member), William M. Greenman (CEO, Chairman and Board Member), William "Obi" Greenman (Chairman) and 7 others.
“We sincerely appreciate your interest in Cirrus. Before I get into the Q2 operating results, I'd like to provide some insight into our recently completed debt refinancing, which included a $30 million reduction in our term loan balance, $20 million from our balance sheet, and $10 million from the lower cost revolver.”
“You've just heard Vivek speak to two of our three pillars, growth and innovation. Today, I'll focus my comments on our third pillar, financial strength. First quarter financial tables are included in today's press release.”
“I'd like to thank you all for your interest in Cerus and for your time with us today. Fourth quarter and full year financial tables are included in today's press release.”
“On today's call, I'll be discussing our financial results for the third quarter of 2025, our increased full-year product revenue guidance, and our expectations surrounding key financial objectives we committed to earlier in the year.”
“On today's call, I'll be discussing our financial results for the second quarter of 2025, our increased full year product revenue guidance, and providing some thoughts on our key metrics as we close out the first half and move into the back half of the year.”
Start not stated–present
Last confirmed April 22, 2026
CERS
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cerus Corp (CERS) | Chief Financial Officer | $507,440 | $1,750,398 |
| 2024 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $488,119 | $1,268,994 |
| 2023 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $484,208 | $1,461,572 |
| 2022 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $464,689 | $2,014,428 |
| 2021 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $443,414 | $2,026,856 |
| 2020 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $425,539 | $1,384,707 |
| 2019 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $406,088 | $1,249,932 |
| 2018 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $386,750 | $1,022,274 |
| 2017 | Cerus Corp (CERS) | Vice President, Finance and Chief Financial Officer | $368,333 | $815,220 |